155
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Analytical and clinical performance of the Advansure i3 procalcitonin assay

&
Pages 546-551 | Received 03 Feb 2021, Accepted 14 Aug 2021, Published online: 04 Oct 2021

References

  • Rhee C. Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis. 2017;4:ofw249.
  • Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev anti Infect Ther. 2010;8(5):575–587.
  • Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–211.
  • Kim H, Hur M, Struck J, et al. Proenkephalin predicts organ failure, renal replacement therapy, and mortality in patients with sepsis. Ann Lab Med. 2020;40(6):466–473.
  • Vincent JL. The clinical challenge of sepsis identification and monitoring. PLoS Med. 2016;13(5):e1002022.
  • Bai X, Yu W, Ji W, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014;18(5):532.
  • Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–1755.
  • Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.
  • Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217.
  • Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34(4):263–273.
  • Wiedermann FJ, Kaneider N, Egger P, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med. 2002;30(5):1112–1117.
  • Covington EW, Roberts MZ, Dong J. Procalcitonin monitoring as a guide for antimicrobial therapy: a review of current literature. Pharmacotherapy. 2018;38(5):569–581.
  • Cho HW, Kim SH, Cho Y, et al. Concordance of three automated procalcitonin immunoassays at medical decision points. Ann Lab Med. 2021;41(4):419–423.
  • Dipalo M, Guido L, Micca G, et al. Multicenter comparison of automated procalcitonin immunoassays. Pract Lab Med. 2015;2:22–28.
  • Liao T, Yuan F, Yu H, et al. An ultrasensitive ELISA method for the detection of procalcitonin based on magnetic beads and enzyme-antibody labeled gold nanoparticles. Anal Methods. 2016;8(7):1577–1585.
  • EP05-A3. Evaluation of precision of quantitative measurement procedures. Wayne (PA): Clinical and Laboratory Standards Institute; 2014.
  • EP06-A. Evaluation of linearity of quantitative measurement procedures. Wayne (PA): Clinical and Laboratory Standards Institute; 2003.
  • EP17-A2. Evaluation of detection capability for clinical laboratory measurement procedures. Wayne (PA): Clinical and Laboratory Standards Institute; 2012.
  • EP09-A3. Measurement procedure comparison and bias estimation using patient samples. Wayne (PA): Clinical and Laboratory Standards Institute; 2013.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
  • Samsudin I, Vasikaran SD. Clinical utility and measurement of procalcitonin. Clin Biochem Rev. 2017;38(2):59–68.
  • de Wolf HK, Gunnewiek JK, Berk Y, et al. Comparison of a new procalcitonin assay from roche with the established method on the brahms kryptor. Clin Chem. 2009;55(5):1043–1044.
  • Eidizadeh A, Asif AR, von Ahsen N, et al. Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (liaison, elecsys and architect). Clin Chem Lab Med. 2019;57(9):e207–e210.
  • Dipalo M, Buonocore R, Gnocchi C, et al. Analytical evaluation of diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800. Clin Chem Lab Med. 2015;53:593–597.
  • Ceriotti F, Marino I, Motta A, et al. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to roche cobas in comparison with BRAHMS PCT-sensitive Kryptor. Clin Chem Lab Med. 2017;56(1):162–169.
  • Song J, Park DW, Moon S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019;19(1):968.
  • Ljungstrom L, Pernestig AK, Jacobsson G, et al. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One. 2017;12(7):e0181704.
  • Jekarl DW, Lee S, Kim M, et al. Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3. J Clin Lab Anal. 2019;33(9):e22996.
  • Kim H, Hur M, Moon HW, et al. Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Ann Intensive Care. 2017;7(1):27.
  • Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762–774.
  • Sager R, Kutz A, Mueller B, et al. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15(1):15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.